Chardan Capital Stock Recommendations and Price Targets

This is a list of recent ratings by Chardan Capital.

DateCompany NameActionCurrent
Price
Price
Target
RatingImpact on
Share Price
10/19/2021
PHGE
BiomX
Lower Price Target$2.00$28.00 ➝ $16.00BuyN/A
10/17/2021
ABUS
Arbutus Biopharma
Reiterated Rating$4.00BuyHigh
10/13/2021
CRSP
CRISPR Therapeutics
Reiterated Rating$100.00 $171.00BuyLow
10/1/2021
RCOR
Renovacor
Initiated Coverage$7.00 $20.00BuyLow
9/30/2021
EDIT
Editas Medicine
Reiterated Rating$39.00 $75.00BuyMedium
9/24/2021
SLDB
Solid Biosciences
Lower Price Target$2.00$20.00 ➝ $17.00BuyHigh
9/20/2021
FBRX
Forte Biosciences
Upgrade$3.00Sell ➝ BuyMedium
9/16/2021
NTLA
Intellia Therapeutics
Reiterated Rating$133.00 $177.00BuyLow
9/10/2021
PRQR
ProQR Therapeutics
Reiterated Rating$8.00 $18.00BuyMedium
9/7/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$28.00BuyMedium
9/3/2021
FBRX
Forte Biosciences
Downgrade$3.00Buy ➝ SellN/A
9/1/2021
NVAX
Novavax
Reiterated Rating$161.00NeutralN/A
8/31/2021
ABUS
Arbutus Biopharma
Reiterated Rating$4.00BuyLow
8/31/2021
MESO
Mesoblast
Lower Price Target$6.00$7.50 ➝ $6.50SellHigh
8/24/2021
TNYA
Tenaya Therapeutics
Initiated Coverage$20.00 $37.00BuyMedium
8/20/2021
IMNM
Immunome
Boost Price Target$18.00$18.00 ➝ $21.00BuyHigh
8/17/2021
TSHA
Taysha Gene Therapies
Lower Price Target$18.00$67.50 ➝ $60.00BuyHigh
8/13/2021
IMVT
Immunovant
Lower Price Target$9.00$55.00 ➝ $22.00BuyHigh
8/13/2021
VINC
Vincerx Pharma
Lower Price Target$14.00$33.00 ➝ $30.00BuyHigh
8/10/2021
DRNA
Dicerna Pharmaceuticals
Lower Price Target$21.00$34.00 ➝ $28.00BuyHigh
8/10/2021
RGNX
REGENXBIO
Reiterated Rating$35.00 $100.00BuyLow
8/10/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$28.00 $56.00BuyMedium
8/9/2021
PRQR
ProQR Therapeutics
Lower Price Target$8.00$20.00 ➝ $18.00BuyLow
8/6/2021
ARWR
Arrowhead Pharmaceuticals
Lower Price Target$67.00$97.00 ➝ $94.00BuyHigh
8/6/2021
NTLA
Intellia Therapeutics
Boost Price Target$133.00$130.00 ➝ $177.00BuyLow
8/4/2021
MCRB
Seres Therapeutics
Reiterated Rating$6.00 $16.00BuyMedium
8/4/2021
ALNY
Alnylam Pharmaceuticals
Reiterated Rating$207.00 $190.00BuyMedium
7/30/2021
AXLA
Axcella Health
Reiterated Rating$3.00 $10.00BuyLow
7/30/2021
EVLO
Evelo Biosciences
Lower Price Target$8.00$15.00 ➝ $12.00NeutralHigh
7/30/2021
CRSP
CRISPR Therapeutics
Lower Price Target$100.00$175.00 ➝ $171.00BuyHigh
7/27/2021
QURE
uniQure
Reiterated Rating$29.00$100.00 ➝ $95.00BuyHigh
7/23/2021
ADVM
Adverum Biotechnologies
Lower Price Target$2.00$5.00 ➝ $3.00NeutralHigh
7/23/2021
MCRB
Seres Therapeutics
Lower Price Target$6.00$30.00 ➝ $16.00BuyMedium
7/13/2021
FEMY
Femasys
Initiated Coverage$7.00 $25.00BuyHigh
7/9/2021
SYBX
Synlogic
Initiated Coverage$3.00 $10.00BuyMedium
7/9/2021
KLDO
Kaleido Biosciences
Initiated Coverage$5.00 $15.00BuyHigh
7/9/2021
EVLO
Evelo Biosciences
Initiated Coverage$8.00 $15.00HoldLow
7/9/2021
MCRB
Seres Therapeutics
Initiated Coverage$6.00 $30.00BuyLow
7/9/2021
FBRX
Forte Biosciences
Initiated Coverage$3.00 $105.00BuyHigh
7/7/2021
SIOX
Sio Gene Therapies
Reiterated Rating$2.00BuyMedium
7/7/2021
LOGC
LogicBio Therapeutics
Reiterated Rating$4.00BuyLow
7/7/2021
FIXX
Homology Medicines
Reiterated Rating$6.00BuyMedium
7/7/2021
ACHL
Achilles Therapeutics
Reiterated Rating$7.00BuyMedium
7/7/2021
LBPS
4D pharma
Reiterated Rating$7.00 $40.00BuyMedium
7/7/2021
PDSB
PDS Biotechnology
Reiterated Rating$12.00BuyHigh
7/7/2021
IMVT
Immunovant
Reiterated Rating$9.00BuyLow
7/7/2021
IMTX
Immatics
Reiterated Rating$13.00BuyLow
7/7/2021
IMNM
Immunome
Reiterated Rating$18.00BuyMedium
7/7/2021
IOVA
Iovance Biotherapeutics
Reiterated Rating$26.00BuyHigh
7/7/2021
RCKT
Rocket Pharmaceuticals
Reiterated Rating$28.00BuyLow
7/7/2021
EDIT
Editas Medicine
Reiterated Rating$39.00BuyMedium
7/7/2021
CRSP
CRISPR Therapeutics
Reiterated Rating$100.00BuyMedium
7/7/2021
NTLA
Intellia Therapeutics
Reiterated Rating$133.00BuyMedium
7/7/2021
MRNA
Moderna
Reiterated Rating$334.00BuyHigh
7/1/2021
SIOX
Sio Gene Therapies
Reiterated Rating$2.00BuyN/A
7/1/2021
ADVM
Adverum Biotechnologies
Reiterated Rating$2.00NeutralMedium
7/1/2021
SLDB
Solid Biosciences
Reiterated Rating$2.00BuyHigh
7/1/2021
AGTC
Applied Genetic Technologies
Reiterated Rating$3.00BuyMedium
7/1/2021
VYGR
Voyager Therapeutics
Reiterated Rating$5.00NeutralHigh
7/1/2021
CFRX
ContraFect
Reiterated Rating$4.00BuyMedium
7/1/2021
CBIO
Catalyst Biosciences
Reiterated Rating$4.00BuyHigh
7/1/2021
PRVB
Provention Bio
Reiterated Rating$6.00BuyMedium
7/1/2021
KLDO
Kaleido Biosciences
Reiterated Rating$5.00BuyLow
7/1/2021
FOLD
Amicus Therapeutics
Reiterated Rating$11.00NeutralMedium
7/1/2021
IMVT
Immunovant
Reiterated Rating$9.00BuyMedium
7/1/2021
PASG
Passage Bio
Reiterated Rating$9.00BuyMedium
7/1/2021
EVLO
Evelo Biosciences
Reiterated Rating$8.00NeutralLow
7/1/2021
MGTX
MeiraGTx
Reiterated Rating$19.00BuyLow
7/1/2021
TSHA
Taysha Gene Therapies
Reiterated Rating$18.00BuyHigh
7/1/2021
MCRB
Seres Therapeutics
Reiterated Rating$6.00BuyLow
7/1/2021
QURE
uniQure
Reiterated Rating$29.00BuyHigh
7/1/2021
FBRX
Forte Biosciences
Reiterated Rating$3.00BuyHigh
7/1/2021
RGNX
REGENXBIO
Reiterated Rating$35.00BuyLow
7/1/2021
KRYS
Krystal Biotech
Reiterated Rating$50.00BuyMedium
6/29/2021
IOVA
Iovance Biotherapeutics
Reiterated Rating$26.00 $51.00BuyHigh
6/26/2021
NTLA
Intellia Therapeutics
Boost Price Target$133.00$85.00 ➝ $130.00BuyHigh
6/10/2021
OCGN
Ocugen
Lower Price Target$8.00$8.00 ➝ $4.50NeutralN/A
6/8/2021
PDSB
PDS Biotechnology
Boost Price Target$12.00$11.00 ➝ $15.00BuyN/A
6/3/2021
VBLT
Vascular Biogenics
Reiterated Rating$2.00 $5.00BuyHigh
6/3/2021
AXLA
Axcella Health
Lower Price Target$3.00$16.00 ➝ $10.00BuyLow
6/2/2021
LOGC
LogicBio Therapeutics
Reiterated Rating$4.00 $20.00BuyHigh
5/28/2021
PRVB
Provention Bio
Lower Price Target$6.00$35.00 ➝ $22.50BuyHigh
5/26/2021
PDSB
PDS Biotechnology
Boost Price Target$12.00$10.00 ➝ $11.00BuyHigh
5/25/2021
PHGE
BiomX
Reiterated Rating$2.00 $28.00BuyN/A
5/25/2021
IOVA
Iovance Biotherapeutics
Lower Price Target$26.00$54.00 ➝ $51.00BuyLow
5/20/2021
PDSB
PDS Biotechnology
Boost Price Target$12.00$10.00 ➝ $11.00BuyHigh
5/19/2021
IOVA
Iovance Biotherapeutics
Lower Price Target$26.00$54.00 ➝ $51.00BuyHigh
5/13/2021
MRNA
Moderna
Boost Price Target$334.00$182.00 ➝ $188.00BuyN/A
5/10/2021
OCGN
Ocugen
Lower Price Target$8.00$13.00 ➝ $8.00NeutralHigh
5/7/2021
MRNA
Moderna
Boost Price Target$334.00$182.00 ➝ $188.00BuyLow
5/6/2021
EBS
Emergent BioSolutions
Lower Price Target$51.00$112.00 ➝ $92.00BuyN/A
5/5/2021
ADVM
Adverum Biotechnologies
Reiterated Rating$2.00$20.00 ➝ $5.00Buy ➝ NeutralLow
5/3/2021
ACHL
Achilles Therapeutics
Initiated Coverage$7.00 $27.00BuyN/A
4/30/2021
EBS
Emergent BioSolutions
Lower Price Target$51.00$112.00 ➝ $92.00BuyMedium
4/29/2021
ADVM
Adverum Biotechnologies
Downgrade$2.00$20.00 ➝ $5.00Buy ➝ NeutralN/A
4/26/2021
ACHL
Achilles Therapeutics
Initiated Coverage$7.00 $27.00BuyMedium
4/26/2021
TSHA
Taysha Gene Therapies
Reiterated Rating$18.00BuyMedium
4/19/2021
PRVB
Provention Bio
Lower Price Target$6.00$35.00 ➝ $22.50BuyN/A
4/19/2021
TSHA
Taysha Gene Therapies
Boost Price Target$18.00$60.00 ➝ $67.50BuyN/A
4/12/2021
PRVB
Provention Bio
Lower Price Target$6.00$35.00 ➝ $22.50BuyLow